{"nct_id":"NCT04274738","title":"A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4","status":"COMPLETED","status_verified_date":"2024-08","start_date":"2020-04-30","start_date_type":"ACTUAL","primary_completion_date":"2022-10-31","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XFOR"]}